G
GRAIL Inc.
GRAL · NASDAQ · Healthcare · 2.9B
Closing price
$140.58
+6.01% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.0×
Enterprise value / EBITDAEV/EBITDA
-13.3×
Free cash flow yieldFCF yield
-5.8%
Return on equityROE
-15.8%
Operating margin
-363.0%
Net debt / EBITDAbalance-sheet strength
0.4×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.